Insider Trading - U.S. Stem Cell Inc. (USRM)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-09-19 Purchase | 2017-03-17 4:00 pm | U.S. Stem Cell Inc. | BHRT.OB | MURPHY WILLIAM P JR Director | 1,200,000 | $0.02 | $24,000 | 1,564,039 (Indirect Direct) | View |
| 2017-08-07 Purchase | 2017-08-25 4:05 pm | U.S. Stem Cell Inc. | USRM | MURPHY WILLIAM P JR Director | 1,799,614 | $0.0277 | $49,849 | 8,115,687 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-02-06 Option Award | 2017-02-17 4:29 pm | N/A 2027-02-06 | U.S. Stem Cell Inc. | BHRT.OB | Comella Kristin C Chief Scientific Officer | 5,000,000 | $0 | 11,697,748 (Direct) | View |
| 2017-02-06 Option Award | 2017-02-17 4:30 pm | N/A 2027-02-06 | U.S. Stem Cell Inc. | BHRT.OB | TOMAS MIKE CEO | 10,000,000 | $0 | 21,851,077 (Direct) | View |
| 2016-09-19 Exercise | 2017-03-31 4:00 pm | N/A N/A | U.S. Stem Cell Inc. | USRM | MURPHY WILLIAM P JR Director | 1,748,947 | $0.0335 | 3,312,986 (Indirect) | View |
| 2017-08-07 Option Award | 2017-08-25 4:00 pm | 2017-08-07 2027-08-07 | U.S. Stem Cell Inc. | USRM | Anderson Sheldon T. Director | 1,500,000 | $0 | 3,003,341 (Direct) | View |
| 2017-08-07 Option Award | 2017-08-25 4:03 pm | 2017-08-07 2017-08-07 | U.S. Stem Cell Inc. | USRM | Borman Mark P Director | 1,500,000 | $0 | 3,002,834 (Direct) | View |
| 2017-08-07 Option Award | 2017-08-25 4:05 pm | 2017-08-07 2027-08-07 | U.S. Stem Cell Inc. | USRM | MURPHY WILLIAM P JR Director | 1,500,000 | $0 | 8,115,687 (Direct) | View |
| 2017-08-07 Option Award | 2017-09-01 4:01 pm | N/A 2027-08-07 | U.S. Stem Cell Inc. | USRM | TOMAS MIKE CEO | 16,500,000 | $0 | 75,192,361 (Direct) | View |
| 2017-08-07 Option Award | 2017-09-01 4:03 pm | N/A 2027-08-07 | U.S. Stem Cell Inc. | USRM | Comella Kristin C Chief Scientific Officer | 9,000,000 | $0 | 39,895,492 (Direct) | View |
| 2018-05-07 Option Award | 2018-05-18 4:01 pm | N/A 2028-05-07 | U.S. Stem Cell Inc. | USRM | Comella Kristin C Chief Scientific Officer | 10,000,000 | $0 | 30,697,746 (Direct) | View |
| 2018-05-07 Option Award | 2018-05-18 4:03 pm | N/A 2028-05-07 | U.S. Stem Cell Inc. | USRM | TOMAS MIKE CEO | 20,000,000 | $0 | 58,551,077 (Direct) | View |
| 2018-10-19 Other | 2018-10-26 4:07 pm | N/A N/A | U.S. Stem Cell Inc. | USRM | Borman Mark P Director | 526,918 | $0.027 | 1,053,860 (Indirect) | View |
| 2018-12-03 Option Award | 2018-12-07 4:00 pm | 2018-12-03 2028-12-03 | U.S. Stem Cell Inc. | USRM | Anderson Sheldon T. Director | 1,500,000 | $0 | 4,503,341 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-07 4:03 pm | 2018-12-03 2028-12-03 | U.S. Stem Cell Inc. | USRM | Borman Mark P Director | 1,500,000 | $0 | 5,029,752 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-07 4:06 pm | 2018-12-03 2028-12-03 | U.S. Stem Cell Inc. | USRM | Comella Kristin C Chief Science Officer | 1,500,000 | $0 | 32,097,746 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-07 4:11 pm | 2018-12-03 2028-12-03 | U.S. Stem Cell Inc. | USRM | Knutson Gregory Director | 1,500,000 | $0 | 33,468,098 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-07 4:15 pm | 2018-12-03 2028-12-03 | U.S. Stem Cell Inc. | USRM | MURPHY WILLIAM P JR Director | 1,500,000 | $0 | 9,615,687 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-07 4:18 pm | 2018-12-03 2028-12-03 | U.S. Stem Cell Inc. | USRM | TOMAS MIKE CEO | 1,500,000 | $0 | 60,051,077 (Direct) | View |
| 2019-11-18 Option Award | 2019-12-20 4:01 pm | 2019-11-18 2029-11-18 | U.S. Stem Cell Inc. | USRM | Borman Mark P Director | 1,500,000 | $0 | 6,529,752 (Direct) | View |
| 2019-11-18 Option Award | 2019-12-20 4:05 pm | 2019-11-18 2029-11-18 | U.S. Stem Cell Inc. | USRM | Anderson Sheldon T. Director | 1,500,000 | $0 | 6,003,341 (Direct) | View |
| 2019-11-18 Option Award | 2019-12-20 4:08 pm | 2019-11-18 2029-11-18 | U.S. Stem Cell Inc. | USRM | Knutson Gregory Director | 1,500,000 | $0 | 34,968,098 (Direct) | View |
| 2019-11-18 Option Award | 2019-12-20 4:12 pm | 2019-11-18 2029-11-18 | U.S. Stem Cell Inc. | USRM | MURPHY WILLIAM P JR Director | 1,500,000 | $0 | 11,115,687 (Direct) | View |
| 2019-09-01 Option Award | 2019-12-20 4:17 pm | N/A 2029-09-01 | U.S. Stem Cell Inc. | USRM | TOMAS MIKE CEO | 21,500,000 | $0 | 161,592,361 (Direct) | View |
| 2020-04-01 Option Award | 2021-07-23 4:02 pm | 2021-02-17 2022-02-17 | U.S. Stem Cell Inc. | USRM | Knutson Gregory Director | 3,759,398 | $100,000 | 48,202,984 (Direct) | View |
| 2020-04-01 Other | 2021-07-23 4:02 pm | N/A N/A | U.S. Stem Cell Inc. | USRM | Knutson Gregory Director | 1,445,647 | $0.006 | 48,202,984 (Indirect) | View |
| 2020-04-01 Other | 2021-07-23 4:02 pm | N/A N/A | U.S. Stem Cell Inc. | USRM | Knutson Gregory Director | 2,035,820 | $0.0045 | 48,202,984 (Indirect) | View |
| 2020-04-01 Other | 2021-07-23 4:02 pm | N/A N/A | U.S. Stem Cell Inc. | USRM | Knutson Gregory Director | 187,575 | $0.0487 | 48,202,984 (Indirect) | View |
| 2021-02-23 Option Award | 2021-07-23 4:03 pm | N/A N/A | U.S. Stem Cell Inc. | USRM | MURPHY WILLIAM P JR Director | 7,518,797 | $0.0266 | 12,445,322 (Indirect) | View |